In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
HALF-LIFE:Excretion of clascoterone has not been fully characterised in humans.
FDA APPROVAL DATE:08/26/2020
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH: No clinical studies evaluating the drug interaction potential of clascoterone (cream) have been conducted.
PREGNANCY: No available data to assess drug-associated risk of clascoterone in pregnant women.
Formulated as a cream with cetyl alcohol and other excipients. Local skin reactions (edema, erythema/redness, skin atrophy, stinging/burning, striae rubrea, telangiectasia) were observed during a treatment period with clascoterone cream, and occurred in a similar percentage of subjects treated with the vehicle cream.
Please login to view the rest of this drug profile.